OncoLens is a powerful tool for the conduct of clinical cancer conferences and care treatment planning. Our oncology focus allows us to assist our clients in optimizing patient care and making the accreditation process easier.
The OncoLens platform:
• Creates and manages tumor board schedules
• Integrates into EMR for efficient collection of data
• Allows for uploading of images from a PC or smartphone
• HIPAA compliant
• Provides CoC/NAPBC/NAPRC accreditation documentation
• Automatically screens for clinical trial eligibility
• Facilitates remote meetings
• Notifies team members of outstanding items
• Real-time collaboration
Benefits of implementing OncoLens:
• Up to a 90% decrease in tumor board time
• Expedited case review
• Increased number of cases reviewed
• Higher quality care
• Increased participation in clinical trials
• Documentation needed for CoC or NAPBC accreditation
Let us help you streamline the cancer conference process. Contact us at support@oncolens.com for a demo.
The OncoLens platform:
• Creates and manages tumor board schedules
• Integrates into EMR for efficient collection of data
• Allows for uploading of images from a PC or smartphone
• HIPAA compliant
• Provides CoC/NAPBC/NAPRC accreditation documentation
• Automatically screens for clinical trial eligibility
• Facilitates remote meetings
• Notifies team members of outstanding items
• Real-time collaboration
Benefits of implementing OncoLens:
• Up to a 90% decrease in tumor board time
• Expedited case review
• Increased number of cases reviewed
• Higher quality care
• Increased participation in clinical trials
• Documentation needed for CoC or NAPBC accreditation
Let us help you streamline the cancer conference process. Contact us at support@oncolens.com for a demo.
Location: United States, Georgia, Atlanta
Employees: 11-50
Phone: +1 404-736-7072
Total raised: $19.85M
Founded date: 2016
Investors 2
| Date | Name | Website |
| - | Panoramic ... | panoramic.... |
| - | BIP Ventur... | bipventure... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 24.10.2024 | Series B | $16M | - |
| 06.01.2020 | Series A | $2.5M | - |
| 27.03.2019 | Seed | $1.35M | - |
Mentions in press and media 25
| Date | Title | Description |
| 24.10.2024 | OncoLens Raises $16M in Series B Funding | Oncolens, an Atlanta, GA-based oncology health tech startup, raised $16m in Series A funding. The round was co-led by BIP Capital and Cross Border Impact Ventures with participaiton from Martin Ventures and SeedToB. The company intends to u... |
| 14.07.2023 | OncoLens Receives Investment from Cross Border Impact Venture Fund | OncoLens, an Atlanta, GA-based company that provides an integration and collaboration platform to cancer centers, received an investment from Cross border Impact Venture Fund. The amount of the deal was not disclosed. The company intends to... |
| 13.07.2023 | OncoLens Welcomes Cross Border Impact Venture Fund as Capital Partner to Fuel International Growth | "With this new investment from Cross Border, we are excited to align our existing and future clients to international collaboration, improved patient care, and revenue opportunities," Anju Mathew, CEO of OncoLens ATLANTA (PRWEB) J... |
| 02.06.2023 | OncoLens Virtual Tumor Board platform connects the best minds, therapies, and innovations in cancer care – in time to make a difference | "We are excited about our partnership with OncoLens and the SARC Multi-Disciplinary Tumor Board," said Dr. Scott Okuno, SARC's chief medical officer and professor of oncology at Mayo Clinic ATLANTA (PRWEB) June 02, 2023 OncoLens a... |
| 06.12.2022 | ACCC and Boston University Present the Project ECHO® eight-part webinar series, powered by OncoLens | ATLANTA (PRWEB) December 06, 2022 OncoLens– an innovator in multidisciplinary cancer care, and provider of a comprehensive, integrated treatment planning platform, was engaged by ACCC to power and disseminate via the OncoLens network, the P... |
| 19.07.2022 | MIB Agents Selects OncoLens to Support and Expand its TURBO Program Globally | “For the TURBO program and global osteosarcoma community, OncoLens is helping streamline multidisciplinary clinical insights, education and access, more effectively and efficiently than ever before," said Matteo Trucco, MD, a pediatric... |
| 04.02.2022 | The Desmoid Tumor Research Foundation Closes Care Gaps through Virtualized Multidisciplinary Cancer Care Platform | ATLANTA (PRWEB) February 04, 2022 In honor of World Cancer Day on February 4th, The Desmoid Tumor Research Foundation (DTRF) is celebrating the success of The DTRF Virtual Tumor Board program in closing care gaps and patient access barriers... |
| 17.08.2021 | New Markey Initiative Helps Affiliates Deliver Cancer Care Closer to Home | The University of Kentucky Markey Cancer Center LEXINGTON, Ky. (PRWEB) August 17, 2021 The University of Kentucky Markey Cancer Center launched a new initiative to create a connected, integrated statewide cancer provider network. As the onl... |
| 14.01.2021 | Fast-Growing Oncology Startup OncoLens Secures $7.25 Million Series a Funding | Since Its Launch in 2017, Atlanta-Based Digital Health It Company Has Grown Rapidly to Become One of the Largest Cancer-Focused Networks in the Country OncoLens, a pioneer in tumor board and cancer treatment planning solutions, announced th... |
| 14.01.2021 | Atlanta startup OncoLens raises $7.25M to expand its cancer treatment platform | Atlanta-based health technology startup OncoLens raised a $7.25 million Series A round to increase its platform and hire more employees. Atlanta’s BIP Capital, Martin Ventures and SeedToB participated in the round, according to a press rele... |
Show more